Heart Failure Study and Impaired Kidney Function Study

This study is testing a new treatment (study drug) for patients with heart failure (HF) and impaired kidney function.

HF is a condition where the heart muscle becomes too weak to properly pump blood around the whole body. HF can cause symptoms such as shortness of breath, tiredness, and swelling of certain tissues, typically of the legs. People with HF often have reduced kidney function, which further increases the risk of heart problems.  

The study is a double-blind study, which means that neither you nor your doctor will know what study drug you are taking. All participants will take both 1 capsule and 1 tablet orally (by mouth) once per day and continue to take their current medication. 

Locations 

  • Sheffield
  • London
  • Cambridge
  • Orpington
  • Glasgow
  • Hastings
  • Exeter
  • Sunderland
 

Link to study on clinicaltrials.gov